[Ceruloplasmin and peptides of medium molecular weight as parameters in development of acute myeloblastic leukemia].
A dynamic content of ceruloplasmin and medium-molecular peptides were studied in the blood serum of 28 patients with an acute clinical course of myeloblast-type leucosis during a scheduled chemotherapy. The mentioned biochemical criteria were shown to be able to characterize indirectly an intensity of the clinical course, functional liver condition and the efficiency of chemotherapy.
Kovtunova
M E
ME
Pan'kov
V N
VN
Perevalova
N N
NN
D000328:Adult; D015415:Biomarkers / Q000097:blood; D002570:Ceruloplasmin / Q000032:analysis*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000175:diagnosis*; D008297:Male; D008875:Middle Aged; D008970:Molecular Weight; D010455:Peptides / Q000097:blood* / Q000737:chemistry
D015415:Biomarkers; D010455:Peptides; D002570:Ceruloplasmin